| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dae64c775f32c43199adbb4389c2c9b3 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-66 |
| filingDate |
1996-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1235f46e34cbfbb202f07f12aaea653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28624b364fd66f461bf30e514b9070fb |
| publicationDate |
1998-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H10158135-A |
| titleOfInvention |
Oral composition |
| abstract |
PROBLEM TO BE SOLVED: To obtain an oral composition which has excellent stability of dextranase and exhibits a high plaque formation inhibitory effect for a long period of time. SOLUTION: Dextranase and a hydroxy-2-pyridone derivative represented by the following general formula (1) or a salt thereof are used in combination. Embedded image (Wherein R 1 and R 2 are each a hydrogen atom or a hydroxyl group, and at least one of R 1 and R 2 is a hydroxyl group. R 3 , R 4 and R 5 are each a hydrogen atom or a monovalent group. Is an organic group.) |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001342122-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4585086-B2 |
| priorityDate |
1996-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |